 |
|
|
| Poster session 2: Lymphoma: Treatment with chemotherapy |
| Date: | Saturday, June 12 2004 |
| Time: | 17:15-18:45 |
| Room: | |
| 17:15-18:45 |
343 |
|
|
AVERAGE RELATIVE DOSE AND DOSE-INTENSITY IN PATIENTS TREATED FOR DIFFUSE LARGE B-CELL LYMPHOMA : A RETROSPECTIVE STUDY IN BELGIUM (1995-2000)
A. Bosly, D. Bron, A. Van Hoof, G. Verhoef (Yvoir, Belgium)
| 17:15-18:45 |
344 |
|
|
AN OUTPATIENT SALVAGE APPROACH FOR NON-HODGKIN'S LYMPHOMA (NHL) AND HODGKIN'S LYMPHOMA (HL) INCORPORATING RISK-FACTOR STRATIFICATION AND TREATMENT ESCALATION
A. Spencer, V. Ganju, A. Grigg, M. Leahy, C. Underhill, J. Catalano, C. Arthur (Melbourne, Australia)
| 17:15-18:45 |
345 |
|
|
AUTOLOGOUS TRANSPLANTATION FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA: 13 YEAR EXPERIENCE AT A SINGLE INSTITUTION
C. Hosing, M.F. Munsell, G.J. Okoroji, J.D. McMannis, D. Couriel, M. De Lima, S. Giralt, L. Fayad, B. Pro, A. Younes, R.E. Champlin, I.F. Khouri (Houston Tx, United States of America)
| 17:15-18:45 |
346 |
|
|
HIGH EFFICACY OF BRIEF DURATION HIGH INTENSITY MULTI AGENT CHEMOTHERAPY FOR TREATMENT OF IMMUNOCOMPETENT ADULT PATIENTS WITH BURKITT’S AND BURKITT-LIKE NON-HODGKIN’S LYMPHOMAS
G.M.F. Aldawsari, N. Chaudhri, E. Sahovic, F.I. ALmohareb, F. AL Sharif, H. AL-Zahrani, H. ALOmer, A. ALShanqeeti, P. Seth, I. ElHassan, M.D. Aljurf (Riyadh, Saudi Arabia)
| 17:15-18:45 |
347 |
|
|
LOW DOSE SINGLE SHOT 2-CHLORODEOXYADENOSINE (2-CDA) IN PATIENTS WITH HAIRY CELL LEUKEMIA
R.Z. Zenhäusern, A. Von Rohr, K. Rufibach, M. Solenthaler, S. Meyer-Monard, A. Gratwohl, U. Hess, M. Bargetzi, T. Kovacsovic, L. Leoncini, A. Tobler (Bern, Switzerland)
| 17:15-18:45 |
348 |
|
|
CHEMOTHERAPY-RELATED NEUTROPENIC EVENTS IN PATIENTS WITH NON HODGKIN'S LYMPHOMA - A COMPARISON OF TWO EUROPEAN AUDITS
A. Bosly, R. Pettengell, M. Constenla, C. Jackisch, R. Leonard, R. Paridaens, T.D. Szucs, M. Schwenkglenks (Mont-godinne, Belgium)
| 17:15-18:45 |
349 |
|
|
PEDIATRIC BURKITT LYMPHOMA TREATED WITH LMB PROTOCOLS
C. Geraldes Santos, M. Brito, M. Benedito, L. Maricato, R. Batista, G. Tamagnini (Coimbra, Portugal)
| 17:15-18:45 |
350 |
|
|
TREATMENT OF HIGH-RISK MEDIASTINAL DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WITH MEGACHOP AND AUTOLOGOUS TRANSPLANT (ASCT)
R. Pytlik, K. Kubacková, P. Zák, M. Jankovská, J. Pirnos, J. Pukyová, T. Papajík, D. Belada, T. Kozák, H. Siffnerová, I. Vásová, M. Hamouzová, M. Trnený (Praha 2, Czech Republic)
| 17:15-18:45 |
351 |
|
|
A(E)BVD CHEMOTHERAPY (CT) PLUS LOW DOSE INVOLVED FIELD RADIATION THERAPY (RT) FOR EARLY CLINICAL STAGE HODGKIN’S LYMPHOMA (HL): THE EFFECT OF RADIATION DOSE ON RELAPSE FREE SURVIVAL (RFS)
T.P. Vassilakopoulos, M.K. Angelopoulou, M.P. Siakantaris, M-C. Kyrtsonis, F.N. Kontopidou, M.N. Dimopoulou, S.I. Kokoris, E. Dimitriadou, P. Tsaftaridis, E. Variamis, H. Zambatis, T. Michalopoulos, V.A. Boussiotis, P. Panayiotidis, G. Papavassiliou, G.A. Pangalis (Athens, Greece)
| 17:15-18:45 |
352 |
|
|
MANAGEMENT OF PRIMARY CUTANEOUS T- AND B-CELL LYMPHOMA WITH INTERFERON ALPHA-2B (IFN-A). A SINGLE CENTER EXPERIENCE
M.P. Siakantaris, M-C. Kyrtsonis, T. Tzenou, E.M. Dimitriadou, M.N. Dimopoulou, M.K. Angelopoulou, S.I. Kokoris, T.P. Vassilakopoulos, P. Korkolopoulou, A. Giannakakis, E. Patsouris, A. Katsambas, G.A. Pangalis (Athens, Greece)
| 17:15-18:45 |
353 |
|
|
HIGH CLINICAL AND MOLECULAR RESPONSE RATES WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND MITOXANTRONE (FCM) IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA (FL)
C. Moreno, A. López-Guillermo, S. Montoto, E. Domingo-Domčnech, J.M. Ribera, A. Altés, C. Estany, J. Besalduch, L. Escoda, C. Pedro, S. Gardella, A. Asensio, A. Fernández-Sevilla, D. Colomer, E. Montserrat (Barcelona, Spain)
|